NCT06987513: RECLAIM STUDY: Phase 2 Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
- State
- Completed
- Phase
- Phase 2
- People
- 100 taking part
- Started
- 15 May 2025
- Primary completion
- 30 Jul 2026
- Arms
- Pemvidutide 2.4 mg
- Results
- None posted
- 15 May 2025: Trial started
- 23 May 2025: Trial registered
- 30 Jul 2026: Trial completed